Trzeciakowski J P
Department of Medical Pharmacology & Toxicology, Texas A&M University Health Science Center, College Station, TX 77843-1115, USA.
J Theor Biol. 1999 Jun 7;198(3):347-74. doi: 10.1006/jtbi.1999.0920.
To understand how deviations from simple binary occupancy affect measures of efficacy, the generalized stimulus function developed in Part I was used to examine the actions of drugs in systems where occupation of the receptor was modeled using a two-state, ternary complex, or combination of mechanisms. Amplification of drug responses can occur during formation of an active agonist-receptor complex, during generation of the initial stimulus, and during signal transduction. Expressions were derived to characterize the separate contributions of these three phases. Ideally, comparison of relative intrinsic efficacy measures differences in the ability of the agonists to convert active complex into an active stimulus. In practice, differences in the ability of the drugs to form the stimulus-generating complex may also contribute to the efficacy ratio and must be taken into consideration. Failure to adequately account for differences in occupancy can result in overestimation of the efficacy ratio. The magnitude of the difference between true and experimental measures of intrinsic efficacy may be affected by G protein concentration, by the affinity between the G protein and receptor, and (in some models) by the receptor activation constant. Provided that the dissociation constant between the G protein and receptor is of the same order of magnitude as, or lower than the receptor concentration, however, experimental estimates should provide reasonably accurate estimates of the true efficacy ratio. In agreement with previously published experimental data, total G protein level was found capable of influencing agonist maximal response, Emax, and EC50 values in all four ternary complex models. The magnitude of the changes in Emax and EC50 appear to be dependent upon the efficacy of the agonist as well as characteristics of the post-receptor stimulus sequence.Additionally, the concentration-response relations for all four ternary complex models could be reduced to a modified operational format in which the apparent dissociation constant Kapp replaced the true KA, and an apparent operational efficacy, tauapp, replaced tau. tauapp can be estimated experimentally from measurements of the Kapp and EC50, while the operational maximum, Em, may be found from the calculated tauapp and the measured Emax of the response curve. These findings support the use of direct operational model-fitting in a variety of systems, regardless of the mechanisms underlying occupancy. Values of Kapp calculated using the exact formula for [ARG] displayed an anomalous rise or discontinuity where the concentrations of total G protein equaled that of the receptor protein. This discontinuity is not observed in the estimates based on approximations to [ARG], and may explain practical difficulties in evaluating the dissociation constant under these conditions.
为了理解偏离简单二元占据对效能测量的影响,我们使用在第一部分中开发的广义刺激函数来研究药物在受体占据采用双态、三元复合物或机制组合模型的系统中的作用。药物反应的放大可发生在活性激动剂 - 受体复合物形成过程中、初始刺激产生过程中以及信号转导过程中。我们推导了表达式来表征这三个阶段的各自贡献。理想情况下,相对内在效能的比较衡量了激动剂将活性复合物转化为活性刺激的能力差异。在实际中,药物形成刺激产生复合物的能力差异也可能对效能比有贡献,必须予以考虑。未能充分考虑占据差异可能导致对效能比的高估。内在效能的真实测量值与实验测量值之间的差异大小可能受G蛋白浓度、G蛋白与受体之间的亲和力以及(在某些模型中)受体激活常数的影响。然而,只要G蛋白与受体之间的解离常数与受体浓度处于相同数量级或更低,实验估计值应能合理准确地估计真实效能比。与先前发表的实验数据一致,在所有四个三元复合物模型中,总G蛋白水平被发现能够影响激动剂的最大反应、Emax和EC50值。Emax和EC50的变化幅度似乎取决于激动剂的效能以及受体后刺激序列的特征。此外,所有四个三元复合物模型的浓度 - 反应关系都可以简化为一种修改后的操作形式,其中表观解离常数Kapp取代了真实的KA,表观操作效能tauapp取代了tau。tauapp可以通过对Kapp和EC50的测量进行实验估计,而操作最大值Em可以从计算出的tauapp和反应曲线的测量Emax中得出。这些发现支持在各种系统中使用直接操作模型拟合,无论占据背后的机制如何。使用[ARG]的精确公式计算的Kapp值在总G蛋白浓度等于受体蛋白浓度的地方显示出异常上升或不连续。在基于[ARG]近似值的估计中未观察到这种不连续性,这可能解释了在这些条件下评估解离常数的实际困难。